Yigal Nochomovitz

Stock Analyst at Citigroup

(3.41)
# 981
Out of 5,090 analysts
327
Total ratings
43.46%
Success rate
5.2%
Average return

Stocks Rated by Yigal Nochomovitz

ORIC Pharmaceuticals
Nov 17, 2025
Maintains: Buy
Price Target: $12$16
Current: $11.29
Upside: +41.72%
Candel Therapeutics
Nov 14, 2025
Maintains: Buy
Price Target: $25$24
Current: $5.24
Upside: +358.02%
Arcturus Therapeutics Holdings
Nov 13, 2025
Maintains: Neutral
Price Target: $12$9
Current: $7.14
Upside: +26.05%
CRISPR Therapeutics AG
Nov 12, 2025
Maintains: Buy
Price Target: $87$77
Current: $58.30
Upside: +32.08%
ArriVent BioPharma
Nov 11, 2025
Maintains: Buy
Price Target: $33$31
Current: $25.38
Upside: +22.14%
Biomea Fusion
Nov 10, 2025
Maintains: Buy
Price Target: $7$6
Current: $1.25
Upside: +380.00%
BeOne Medicines AG
Nov 10, 2025
Maintains: Buy
Price Target: $399$405
Current: $313.38
Upside: +29.24%
Solid Biosciences
Nov 5, 2025
Maintains: Buy
Price Target: $16$14
Current: $5.87
Upside: +138.50%
Krystal Biotech
Nov 4, 2025
Maintains: Neutral
Price Target: $166$198
Current: $226.13
Upside: -12.44%
Ardelyx
Nov 3, 2025
Maintains: Buy
Price Target: $10$11
Current: $5.81
Upside: +89.49%
Maintains: Buy
Price Target: $5$8
Current: $1.88
Upside: +325.89%
Maintains: Buy
Price Target: $52$45
Current: $23.86
Upside: +88.60%
Maintains: Buy
Price Target: $54$56
Current: $25.21
Upside: +122.13%
Maintains: Buy
Price Target: $175$203
Current: $155.36
Upside: +30.66%
Maintains: Buy
Price Target: $27$46
Current: $39.63
Upside: +16.07%
Initiates: Buy
Price Target: $33
Current: $27.34
Upside: +20.70%
Maintains: Buy
Price Target: $35$40
Current: $18.35
Upside: +117.98%
Downgrades: Neutral
Price Target: $101$97
Current: $96.19
Upside: +0.84%
Maintains: Buy
Price Target: $20$21
Current: $27.12
Upside: -22.57%
Maintains: Buy
Price Target: $66$69
Current: $19.46
Upside: +254.57%
Maintains: Buy
Price Target: $19$22
Current: $26.19
Upside: -16.00%
Maintains: Buy
Price Target: $1.2$1.9
Current: $1.39
Upside: +36.69%
Maintains: Buy
Price Target: $46$51
Current: $19.92
Upside: +156.02%
Maintains: Buy
Price Target: $49$52
Current: $28.00
Upside: +85.71%
Initiates: Sell
Price Target: $7
Current: $22.48
Upside: -68.85%
Maintains: Buy
Price Target: $6$9
Current: $2.37
Upside: +279.75%
Maintains: Neutral
Price Target: $10$9.5
Current: $12.68
Upside: -25.08%
Maintains: Buy
Price Target: $49$55
Current: $48.65
Upside: +13.05%
Initiates: Buy
Price Target: $33
Current: $17.20
Upside: +91.86%
Maintains: Buy
Price Target: $13$8
Current: $0.22
Upside: +3,534.71%
Downgrades: Neutral
Price Target: $8$2
Current: $2.94
Upside: -31.86%
Maintains: Buy
Price Target: $60$58
Current: $35.90
Upside: +61.56%
Maintains: Buy
Price Target: $16$14
Current: $1.34
Upside: +944.78%
Maintains: Neutral
Price Target: $3.5$1.2
Current: $1.70
Upside: -29.41%
Maintains: Neutral
Price Target: $1.8$2
Current: $2.04
Upside: -1.96%
Maintains: Buy
Price Target: $25$8
Current: $4.84
Upside: +65.29%
Maintains: Neutral
Price Target: $1.5$1
Current: $5.68
Upside: -82.39%
Maintains: Sell
Price Target: $50$35
Current: $14.20
Upside: +146.48%
Maintains: Buy
Price Target: $130$133
Current: $37.00
Upside: +259.46%
Maintains: Buy
Price Target: $24$16
Current: $4.69
Upside: +241.15%
Maintains: Buy
Price Target: $9$10
Current: $1.09
Upside: +821.66%
Maintains: Buy
Price Target: $16$12
Current: $1.96
Upside: +512.24%
Upgrades: Buy
Price Target: n/a
Current: $5.25
Upside: -